Crisnatol Explained

Crisnatol (BW-A770U) is an experimental anticancer agent. A Phase I clinical trial was published in 1999.^[1]

Notes and References

1. Villalona-Calero MA, Petit T, Kuhn J, Cobb P, Kraynak M, Eckhardt SG, Drengler R, Simmons C, Santabarbara P, Von Hoff DD, Rowinsky EK . 6 . A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies . Clinical Cancer Research . 5 . 11 . 3369–78 . November 1999 . 10589747 .